Dr
Isaac OseiProfile page
Research Fellow
GM-Disease Control and Elimination Theme
- Research FellowGM-Disease Control and Elimination Theme
- +220 7918069 (Mobile)
- +233 244 972250 (Mobile)
RESEARCH INTERESTS
My research interest is in infectious diseases and vaccine-related research, including pneumonia, meningitis and malaria. I am interested in studying how infectious diseases spread within populations, identifying factors contributing to their transmission, and developing strategies to prevent and control outbreaks at a population level. I am currently investigating the relationship between pneumococcal carriage and interpersonal contact patterns and its role in persistent vaccine-type pneumococcal carriage in high-transmission settings.
GRANTS
- Showing page 1 out of 1
- 1
- MRC UNIT RESEARCH GRANTKlebsiella and E Coli in Gambia15 Dec 2023People funded by this grant: Osei IThis fund is to support research into outbreak of Klebsiella pneumoniae at the Bansang Hospital
- MRC UNIT RESEARCH GRANTPVS Stakeholder engagement19 Jun 2023People funded by this grant: Osei IWe assessed the caregivers and healthcare provider acceptability of the alternate schedule compared to the standard PCV schedule
- MRC UNIT RESEARCH GRANTMRC IIB Acquisition follow-up31 Dec 2021People funded by this grant: Osei IThis fund was to enable participants enrolled in the Acquisition study to be followed-up to 28 months
- MRC UNIT RESEARCH GRANTWill the ongoing use of a two-dose, rather than three-dose schedule of pneumococcal conjugate vaccine, have similar impact in rural Gambia?1 Feb 2018 - 30 Jun 2025People funded by this grant: Greenwood B, Flasche S, D'Alessandro U, Osei I, Secka OCluster-randomised trial of pneumococcal vaccine schedules in rural Gambia
- MRC UNIT RESEARCH GRANTWill the ongoing use of a two-dose, rather than three-dose schedule of pneumococcal conjugate vaccine, have similar impact in rural Gambia?1 Jan 2018 - 30 Jun 2025People funded by this grant: Osei I, Greenwood B, Mackenzie G, D'Alessandro UWill the ongoing use of a two-dose, rather than three-dose schedule of pneumococcal conjugate vaccine, have similar impact in rural Gambia?